Laurel McGrane

Fimbrion Therapeutics, Inc.

NIH Rank #26494
  • Early Career

NIH Funding · FY2024

Total Funding
$600K
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#26,494
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $600K across 2 grants · National rank #26494.

Top grants by award amount

Laurel McGrane's NIH grant portfolio, ranked by award amount.

  • 5R43AI174482-02R43
    FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
    $300K
    award amount
  • 5R43AI172559-02R43
    Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
    $300K
    award amount

Affiliation

Institutions that have administered grants for Laurel McGrane.

Affiliated with Fimbrion Therapeutics, Inc. (MO).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fimbrion Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding

Related investigators

Other NIH-funded PIs frequently associated with Laurel McGrane.